These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10819555)

  • 21. Patch testing in an unusual case of toxic epidermal necrolysis.
    Klein CE; Trautmann A; Zillikens D; Bröcker EB
    Contact Dermatitis; 1995 Dec; 33(6):448-9. PubMed ID: 8706422
    [No Abstract]   [Full Text] [Related]  

  • 22. Cutaneous artifactual disease represented as recurrent toxic epidermal necrolysis.
    Gowring LE; Johnson R; Hivnor CM; Henning JS
    Cutis; 2016 Sep; 98(3):E6-E7. PubMed ID: 27814420
    [No Abstract]   [Full Text] [Related]  

  • 23. Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.
    Ririe MR; Blaylock RC; Morris SE; Jung JY
    J Am Acad Dermatol; 2013 Aug; 69(2):221-5. PubMed ID: 23673282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of toxic epidermal necrolysis in AIDS with intravenous immunoglobulins.
    Tan A; Tan HH; Lee CC; Ng SK
    Clin Exp Dermatol; 2003 May; 28(3):269-71. PubMed ID: 12780710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis: An Indian perspective.
    Gupta LK; Martin AM; Agarwal N; D'Souza P; Das S; Kumar R; Pande S; Das NK; Kumaresan M; Kumar P; Garg A; Singh S
    Indian J Dermatol Venereol Leprol; 2016; 82(6):603-625. PubMed ID: 27716721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe cutaneous adverse reactions to drugs.
    Chia FL; Leong KP
    Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):304-9. PubMed ID: 17620821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous immunoglobulin for treatment of toxic epidermal necrolysis.
    Nasser M; Bitterman-Deutsch O; Nassar F
    Am J Med Sci; 2005 Feb; 329(2):95-8. PubMed ID: 15711426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vanishing bile duct syndrome in a child with toxic epidermal necrolysis: an interplay of unbalanced immune regulatory mechanisms.
    Karnsakul W; Arkachaisri T; Atisook K; Wisuthsarewong W; Sattawatthamrong Y; Aanpreung P
    Ann Hepatol; 2006; 5(2):116-9. PubMed ID: 16807519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxic epidermal necrolysis triggered by clobazam: a case report in a 13-year-old girl.
    Dang CD; Beets-Shay L; Kahn EC
    Pediatr Dermatol; 2015; 32(3):e102-3. PubMed ID: 25690725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of toxic epidermal necrolysis.
    Craven NM
    Hosp Med; 2000 Nov; 61(11):778-81. PubMed ID: 11198746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wound care for Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Castillo B; Vera N; Ortega-Loayza AG; Seminario-Vidal L
    J Am Acad Dermatol; 2018 Oct; 79(4):764-767.e1. PubMed ID: 29601936
    [No Abstract]   [Full Text] [Related]  

  • 32. Ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with AIDS.
    Belfort R; de Smet M; Whitcup SM; Pavesio C; Lottenberg C; Rubin B; Lopez JS; Nussenblatt R
    Cornea; 1991 Nov; 10(6):536-8. PubMed ID: 1782783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Toxic epidermal necrolysis (drug-induced Lyell's syndrome). 2. Treatment].
    Konstantinow A; Mühlbauer W; Balda BR; Ring J
    Dtsch Med Wochenschr; 2001 Feb; 126(7):177-9. PubMed ID: 11236525
    [No Abstract]   [Full Text] [Related]  

  • 34. A case of toxic epidermal necrolysis caused by trimethoprim-sulfamethoxazole.
    Rijal JP; Pompa T; Giri S; Bhatt VR
    BMJ Case Rep; 2014 Jul; 2014():. PubMed ID: 25008332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Stevens-Johnson syndrome/toxic epidermal necrolysis].
    Watanabe H; Iijima M
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():336-40. PubMed ID: 18072345
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful desensitization of two patients who previously developed Stevens-Johnson syndrome while receiving trimethoprim-sulfamethoxazole.
    Douglas R; Spelman D; Czarny D; O'Hehir RE
    Clin Infect Dis; 1997 Dec; 25(6):1480. PubMed ID: 9431406
    [No Abstract]   [Full Text] [Related]  

  • 37. Heterotopic ossification as a complication of toxic epidermal necrolysis.
    Gibson CJ; Poduri KR
    Arch Phys Med Rehabil; 1997 Jul; 78(7):774-6. PubMed ID: 9228883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stevens-Johnson syndrome and toxic epidermal necrolysis treatments: An Internet survey.
    Curtis JA; Christensen LC; Paine AR; Collins Brummer G; Summers EM; Cochran AL; Petersen MJ; Hull CM
    J Am Acad Dermatol; 2016 Feb; 74(2):379-80. PubMed ID: 26775781
    [No Abstract]   [Full Text] [Related]  

  • 39. Stevens-Johnson syndrome and toxic epidermal necrolysis: efficacy of intravenous immunoglobulin and a review of treatment options.
    Teo L; Tay YK; Liu TT; Kwok C
    Singapore Med J; 2009 Jan; 50(1):29-33. PubMed ID: 19224081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ecthyma gangrenosum in a patient with toxic epidermal necrolysis.
    Downey DM; O'Bryan MC; Burdette SD; Michael JR; Saxe JM
    J Burn Care Res; 2007; 28(1):198-202. PubMed ID: 17211226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.